ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ferritin-Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy

Liu, Rong; Liang, Qian; Luo, Jia-Qi; Li, Yu-Xuan; Zhang, Xin; Fan, Kelong*; Du, Jin-Zhi*郑州大学; 中国科学院研究生院; 中国科学院
Advanced Science2024-1DOI: 10.1002/advs.202305217
1被引7阅读
引用收藏
分享

摘要

Hydrogels are prevailing drug delivery depots to improve antitumor efficacy and reduce systemic toxicity. However, the application of conventional free drug-loaded hydrogel is hindered by poor drug penetration in solid tumors. Here, an injectable ferritin-based nanocomposite hydrogel is constructed to facilitate tumor penetration and improve cancer chemoimmunotherapy. Specifically, doxorubicin-loaded human ferritin (Dox@HFn) and oxidized dextran (Dex-CHO) are used to construct the injectable hydrogel (Dox@HFn Gel) through the formation of pH-sensitive Schiff-base bonds. After peritumoral injection, the Dox@HFn Gel is retained locally for up to three weeks, and released intact Dox@HFn gradually, which can not only facilitate tumor penetration through active transcytosis but also induce immunogenic cell death (ICD) to tumor cells to generate an antitumor immune response. Combining with anti-programmed death-1 antibody (alpha PD-1), Dox@HFn Gel induces remarkable regression of orthotopic 4T1 breast tumors, further elicits a strong systemic anti-tumor immune response to effectively suppress tumor recurrence and lung metastasis of 4T1 tumors after surgical resection. Besides, the combination of Dox@HFn GelL with anti-CD47 antibody (alpha CD47) inhibits postsurgical tumor recurrence of aggressive orthotopic glioblastoma tumor model and significantly extends mice survival. This work sheds light on the construction of local hydrogels to potentiate antitumor immune response for improved cancer therapy. @@@ In this study, a ferritin (HFn)-based nanocomposite hydrogel is designed for cancer chemoimmunotherapy. The hydrogel can release intact drug-loaded HFn nanocage in vivo and thus improve the penetration into tumor parenchyma through its active transcytosis and generates an immunostimulatory tumor microenvironment through ICD effect. The hydrogel shows superior antitumor efficacy in aggressive 4T1 breast and GL261 glioblastoma tumor models.image

学科与关键词

关键词
cancer chemoimmunotherapyferritinhydrogeltranscytosistumor penetration
相关
加载中…
  • An Injectable Nanocomposite Hydrogel Improves Tumor Penetration and Cancer Treatment Efficacy
    Luo, Feng-Qin; Xu, Wei; Zhang, Jing-Yang; Liu, Rong; Huang, Yong-Cong; Xiao, Chunsheng*; Du, Jin-Zhi*Acta Biomaterialia, 2022, 147: 235-244.被引 13
  • Injectable Supramolecular Hydrogel for Locoregional Immune Checkpoint Blockade and Enhanced Cancer Chemo-Immunotherapy
    Liu, Mengting; Cao, Ziyang; Zhang, Runlin; Chen, Yunhua; Yang, Xianzhu*ACS applied materials & interfaces, 2021, 13(29): 33874-33884.被引 32
  • Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment
    Liu, Yushuai; Geng, Yuanyuan; Yue, Beilei; Lo, Pui-Chi; Huang, Jing*; Jin, Honglin*Frontiers in Immunology, 2022, 13: 832942.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
Advanced Science
发表日期
2024-01
卷期
第 11 卷, 第 3 期
DOI
10.1002/advs.202305217
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China; National Natural Science Foundation of China [52173122, 51922043, 32201167]; Guangdong Basic and Applied Basic Research Foundation [2022B1515120028]; [2022YFB3804600]; [2021YFA1201102]

作者

  • L

    Liu, Rong (第一作者)

  • L

    Liang, Qian

    cas · chinese acad sci

查看全部 7 位作者收起作者
  • L

    Luo, Jia-Qi

  • L

    Li, Yu-Xuan

  • Z

    Zhang, Xin

  • F

    Fan, Kelong (通讯)

    zhengzhou univ · univ chinese acad sci · cas · chinese acad sci

  • D

    Du, Jin-Zhi (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417